Search PDMR transactions

Notifier
Name
Diamyd Medical Aktiebolag
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Anders Essen-Möller
Position
Styrelseledamot/suppleant
Initial notification
Yes
Amendment
No
Details of amendment
Issuer
Name of issuer
NextCell Pharma AB
LEI code
549300PBFGB5JYKXGA45
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Trading venue
BTA NextCell Pharma AB BTA SE0012702538 Acquisition 981,394 Quantity 3.25 SEK 20/06/2019 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Trading venue Volume Weighted average price
NextCell Pharma AB BTA SE0012702538 Acquisition 20/06/2019 Outside a trading venue 981,394 (Quantity) 3.25 SEK
Total: 981,394
<< Back